BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Drug Development

  GSK’s Injectable HIV Drug Bests Pills in Patients with Medication Adherence Issues

  ViiV Healthcare and GSK’s Cabenuva in a Phase III study showed superior efficacy versus daily oral antiretroviral treatment in HIV patients with a history of difficulties in taking daily pills.

  February 21, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Career Advice

  Data Analysts Take on Greater Role Amid Data Explosion in Biopharma

  Artificial intelligence and a flood of data in the pharmaceutical industry will likely change some of the current functions of its data scientists, experts say, but the ability to learn and adapt to new technologies will remain key in this role.

  February 21, 2024

   · 

  4 min read

   · 

  Alejandra Manjarrez
• 

  Policy

  Four Drugmakers to Face Government Together in IRA Oral Arguments Next Month

  A federal judge in New Jersey has agreed to hear legal challenges from BMS, J&J, Novartis and Novo Nordisk to the Inflation Reduction Act’s Drug Price Negotiation Program during the same March 7 hearing.

  February 21, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Policy

  United Therapeutics Files Lawsuit Against FDA to Keep Exclusivity in PH-ILD Market

  The litigation alleges the regulator allowed its competitor Liquidia to skirt FDA precedents by amending an already pending NDA to add a PH-ILD indication instead of filing a new application.

  February 21, 2024

   · 

  2 min read

   · 

  Kate Goodwin
• 

  FDA

  J&J Wins Bi-Weekly Dosing Approval from FDA for Tecvayli in Multiple Myeloma

  Johnson & Johnson’s anti-BCMA antibody can now be dosed once every two weeks in relapsed or refractory multiple myeloma patients who have achieved and maintained complete response for at least six months.

  February 21, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Business

  10 Multibillion-Dollar M&As That Closed Since July 2023

  After a slow start to 2023 in an uncertain economic climate, biopharma mergers and acquisitions are on the rise.

  February 21, 2024

   · 

  6 min read

   · 

  Neil Versel
• 

  Business

  AbbVie CEO Gonzalez to Retire July 1 After More Than a Decade at Helm

  President and COO Robert Michael will take over Richard Gonzalez’s CEO duties, AbbVie announced Tuesday. Gonzalez will become executive chairman of the board of directors.

  February 21, 2024

   · 

  2 min read

   · 

  Tyler Patchen
• 

  Business

  Bavarian Nordic Puts Kibosh on Cancer Vaccine, Focuses on Infectious Diseases

  Danish biotech Bavarian Nordic announced Wednesday it is discontinuing its immuno-oncology program and will focus its R&D efforts on infectious diseases.

  February 21, 2024

   · 

  1 min read

   · 

  Tyler Patchen
• 

  Drug Development

  We Don’t Know What We Don’t Know: LGBTQIA+ Patient Data and the Struggle for Inclusivity

  With over 20% of people born between 1997 and 2003 identifying as a sexual and gender minority, moderated panels at SCOPE 2024 discuss the need to engage this community in clinical trials.

  February 21, 2024

   · 

  7 min read

   · 

  Lori Ellis
• 

  Job Trends

  5 Companies Hiring Sales Professionals

  If you’re a sales professional looking for a new position, here are some companies currently looking to fill sales roles on BioSpace.

  February 21, 2024

   · 

  1 min read

   · 

  BioSpace Editorial Staff